|
![]() |
|||
|
||||
OverviewThis book is a cutting-edge resource that provides clinicians with the up-to-date practical knowledge required in order to manage SCC patients optimally. It summarizes newly available information relating to the definition of high-risk SCC, its pathophysiologic underpinnings, and its management. New prognostic information and staging systems are summarized that enable high-risk tumors to be defined more precisely than ever before. Many helpful tips are provided on the practical management of challenging cases, including multiple tumors/field cancerization, high-risk tumors, nodal metastases, and unresectable disease. The authors are all acknowledged experts in the emerging field of high-risk and advanced SCC. Full Product DetailsAuthor: Chrysalyne D. SchmultsPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: Softcover reprint of the original 1st ed. 2016 Weight: 0.559kg ISBN: 9783662568910ISBN 10: 3662568918 Pages: 255 Publication Date: 27 May 2018 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of Contents1. Introduction.- 2. DEFINING THE PROBLEM OF HIGH-RISK SCC: Epidemiology and Outcomes of SCC/Scope of The Problem.- 3. The Evidence For Clinical and Histologic Risk Predictors.- 4. Tumor Staging Systems and Prognostic Stratification.- 5. THE SCIENCE OF SCC: Molecular/Genetic Underpinnings of Tumorormation/Progression/Metastasis/Immunosurveillance.- 6. MANAGEMENT: Management of Patients With Multiple Sccs/Field Cancerization.- 7. Management of High-Risk Primary Tumors.- 8. Management of Extensive Local Recurrence/In-Transit Metastasis.- 9. Management of Nodal Metastases.- 10. Management of Widely Metastatic and Unresectable Disease.ReviewsThis book explores the immune and epigenetic mechanisms responsible for the development of squamous cell carcinoma. ... The audience is dermatologists and oncologists. ... When faced with a patient with a high-risk squamous cell carcinoma, this is the reference to turn to for the most up-to-date, multidisciplinary approach. (Patricia Wong, Doody's Book Reviews, August, 2016) “This book explores the immune and epigenetic mechanisms responsible for the development of squamous cell carcinoma. … The audience is dermatologists and oncologists. … When faced with a patient with a high-risk squamous cell carcinoma, this is the reference to turn to for the most up-to-date, multidisciplinary approach.” (Patricia Wong, Doody’s Book Reviews, August, 2016) Author InformationChrysalyne Schmults, MD, MSCE Director, Mohs & Dermatologic Surgery Center Brigham & Women’s Hospital Department of Dermatology 1153 Centre St., Suite 4349 Jamaica Plain, MA 02130, USA Tab Content 6Author Website:Countries AvailableAll regions |